Recurrent Failures in assIsted Reproductive Techniques (The FIRST Registry)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02685800|
Recruitment Status : Recruiting
First Posted : February 19, 2016
Last Update Posted : January 31, 2019
Assisted Reproductive Technologies (ARTs) are widely used in couples with fertility problems. However, despite ART treatment options have evolved over time, the implantation rate remains rather low.
A possible role for inherited and acquired thrombophilias has been invoked, especially in women with previous implantation failures. However, several factors could play a role in these conditions.
A potential benefit of low-molecular-weight heparin (LMWH) in improving ART outcomes, independently of the presence of thrombophilia, has been recently suggested.
This register is designed in order to better define all possible variables influencing ART outcome and improve clinical management of women with previous implantation failures. During this study the investigators will collect and evaluate clinical data regarding the first cycle in women with previous ART failures.
|Condition or disease|
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||624 participants|
|Target Follow-Up Duration:||10 Months|
|Official Title:||A Registry on Outcomes in Women Undergoing Assisted Reproductive Techniques After Recurrent Failures|
|Study Start Date :||October 2015|
|Estimated Primary Completion Date :||September 2020|
|Estimated Study Completion Date :||September 2020|
- Number of live births [ Time Frame: 10 months ]
- Number of clinical pregnancies after ART [ Time Frame: 10 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02685800
|Contact: Elvira Grandonefirstname.lastname@example.org|
|Contact: Michela Villaniemail@example.com|
|IRCCS Casa Sollievo della Sofferenza||Recruiting|
|San Giovanni Rotondo, Foggia, Italy, 71013|
|Contact: Elvira Grandone|
|Principal Investigator:||Elvira Grandone||IRCCS Casa Sollievo della Sofferenza - San Giovanni Rotondo, Foggia, Italy|